跳至主要内容
临床试验/NCT01211886
NCT01211886Unknown不适用

Utility of BNP in Patients With Type IV Cardio-renal Syndrome Admitted to the ICU: a Prospective Observational Study

Hallym University Medical Center0 个研究点目标入组 83 人开始时间: 2010年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
83

研究概览

简要总结

Admission BNP was a useful marker for diagnosing and predicting type IV cardio-renal syndrome type IV in patients with chronic kidney disease admitted to the ICU for acute heart failure in a retrospective study. Therefore, we aim to prospectively investigate the utility of serum BNP in evaluating the treatment adequacy and predicting future cardiac events in patients with type IV CRS.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients aged > 18 years, Patients with chronic kidney disease (Serum Cr > 2.0, Documented medical history of chronic kidney disease

排除标准

  • Cardiopulmonary resuscitation, Do-not-resuscitate state, Acute kidney injury, ICU stay < 1 day

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Utility of Brain Natriuretic Peptide (BNP) in... | 临床试验